Comprehension Study Protocol
Item
capacity to understand the procedures of the study.
boolean
C0162340 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Informed Consent
Item
to agree voluntarily to participate of the study, signing an informed consent.
boolean
C0021430 (UMLS CUI [1])
Body Weight Variability
Item
weight variance less than 5% in the last 3 months.
boolean
C0005910 (UMLS CUI [1,1])
C2827666 (UMLS CUI [1,2])
Group Operative | Follow-up
Item
operative group with at least 2 year follow-up.
boolean
C0441833 (UMLS CUI [1,1])
C1882154 (UMLS CUI [1,2])
C3274571 (UMLS CUI [2])
Liver disease | Liver Cirrhosis | Hepatitis, Chronic
Item
history of hepatic disease like cirrhosis or chronic active hepatitis.
boolean
C0023895 (UMLS CUI [1])
C0023890 (UMLS CUI [2])
C0019189 (UMLS CUI [3])
Abnormal renal function | Creatinine measurement, serum | Gender
Item
kidney dysfunction (creatinine > 1,4 mg/dl in women and > 1,5 mg/dl in men).
boolean
C0151746 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0079399 (UMLS CUI [3])
Liver Dysfunction | Alanine aminotransferase increased | Aspartate aminotransferase increased
Item
hepatic dysfunction: alt and/or ast 3x above upper normal limit).
boolean
C0086565 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
C0151904 (UMLS CUI [3])
Neoplastic disease
Item
recent history of neoplasia (< 5 years).
boolean
C1882062 (UMLS CUI [1])
Oral medication | Injectables
Item
use of oral or injectable for more than consecutive 14 days in the last three months.
boolean
C0175795 (UMLS CUI [1])
C0086466 (UMLS CUI [2])